Background Ineffective communication between healthcare providers is a known risk factor for adverse events. Objective The aim of this study was to retrospectively assess the communication with pathology via an analysis of the information provided on the pathology requisitions over ten years. Methods All in-house surgical specimens and all non-gynecologic cytopathology specimens accessioned from 2011 to 2020 were retrieved at a regional laboratory. Cases with any clinical information were deemed to have a clinical history present (CHP). CHP was tabulated by submitting physicians/surgeons (SPS), hospital site, year, and tissue group. Results The study period contained 554,817 relevant pathology reports, of which 553,966 could be extracted. The overall CHP rate was 74% and varied from 76% to 67% over the study period. SPSes submitting ≥200 cases (n=314) had a mean/median/standard deviation/max/min CHP rate of 81%/92%/23%/100%/5%. The CHP varied between four hospital sites, from 53% to 97%. CHP varied from 61% to 99% by tissue group. Conclusions CHP is associated with several factors and appears to depend on the hospital culture, specialty, and individual physician/surgeon. The pathology requisition is a way to measure and track the communication that is clinically relevant. Improving communication with pathologists/the pathology department will likely require process changes and mandates. Hospital and laboratory accreditation bodies should consider effective communication with pathology a marker of quality and an accreditation issue.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441211 | PMC |
| http://dx.doi.org/10.7759/cureus.27714 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis: A Scoping Review.
JAMA Dermatol
December 2024
Sydney School of Public Health, The University of Sydney, Sydney, Australia.
Article Synopsis
- Poor accuracy and reproducibility in diagnosing melanocytic skin lesions can potentially be improved by providing clinical information to pathologists.
- A review of studies from various countries showed that clinical images and information increased diagnostic certainty, leading to more agreement among pathologists and upgraded diagnoses in a notable percentage of cases.
- While including clinical details may help prevent missed melanomas, further research is necessary to understand the full implications of integrating clinical information with histopathology diagnoses.
A Retrospective Analysis of Concordance Between Clinical and Histopathologic Diagnoses and Completeness of Oral Biopsy Forms at a Tertiary Dental Hospital in Eastern Nepal.
Int J Dent
October 2024
Department of Oral Pathology College of Dental Surgery B.P. Koirala Institute of Health Sciences, Dharan, Nepal.
Article Synopsis
- Histopathological diagnosis is crucial for identifying oral and maxillofacial conditions, but accurate clinical descriptions are essential for proper diagnosis.
- A study analyzed 338 biopsy request forms to assess the agreement between clinical and histopathological diagnoses, finding a 71.89% total concordance rate, though some forms lacked critical clinical details.
- The study concluded that good levels of agreement exist between diagnoses, emphasizing the importance of thorough clinical information on requisition forms for improving diagnostic accuracy.
Biological Reference Ranges for Healthy Indian Blood Donors: Experience of a Tertiary Care Center Vis-à-Vis International Literature.
Int J Lab Hematol
February 2025
Regional Scientific Affairs, Sysmex Asia Pacific Pvt Ltd., Tampines Grande, Singapore.
Introduction: Complete blood count is the most common, basic test requisitioned in hematology. The normal reference ranges of hematological parameters are required owing to variable socioeconomic, environmental, and genetic factors in populations. The current study determines the reference ranges of the healthy Indian donor population of a high socioeconomic group.
View Article and Find Full Text PDFPoor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing.
Commun Med (Lond)
September 2024
Natera Inc, Austin, TX, USA.
Background: Approximately 15% of colorectal cancers (CRCs) are associated with germline mutations. There is increasing adoption of DNA-based assays for molecular residual disease (MRD) and growing evidence supporting its clinical utility, particularly for CRC by oncologists in the U.S.
View Article and Find Full Text PDFUse of UV mutational signatures to distinguish between cutaneous and pulmonary primary squamous cell carcinoma.
J Cutan Pathol
September 2024
SUNY Upstate Medical University, Syracuse, New York, USA.
Background: Squamous cell carcinoma (SCC) of presumed lung origin (PLO) is now the second most frequent histologic subtype of non-small cell carcinoma after adenocarcinoma. The use of clinic-genomic correlation provided by comprehensive genomic profiling (CGP) can revise clinicopathologic diagnoses of presumed primary lung SCC (PLO-SCC) to diagnoses of metastatic SCC of cutaneous origin (C-SCC).
Design: A total of 10 146 samples of clinically advanced PLO-SCC (84% known Stage IV) passed QC metrics and were designated as PLO-SCCs by review of test requisition forms, clinical notes, and pathology reports.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!